Differences in sialic acid O-acetylation between human urinary and recombinant erythropoietins: a possible mass spectrometric marker for doping control-Reference-Cited by-同舟云学术

Differences in sialic acid O-acetylation between human urinary and recombinant erythropoietins: a possible mass spectrometric marker for doping control

Published:2013-11 Issue:11-12 Volume:5 Page:877-889
ISSN:1942-7603
Container-title:Drug Testing and Analysis
language:en
Short-container-title:Drug Test. Analysis

Author:

Reichel Christian¹

Affiliation:

1. Doping Control Laboratory, AIT Seibersdorf Laboratories; A-2444 Seibersdorf Austria

Publisher

Wiley

Subject

Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/dta.1563/fullpdf

Reference40 articles.

1. World Anti-Doping Agency (WADA) The World Anti-Doping Code The 2013 Prohibited List. International Standard http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2013/WADA-Prohibited-List-2013-EN.pdf 2013

2. Recombinant erythropoietin in urine;Lasne;Nature,2000

3. Detection of isoelectric profiles of erythropoietin in urine: Differentiation of natural and administered recombinant hormones;Lasne;Anal. Biochem.,2002

4. Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels;Kohler;Int. J. Sports Med.,2008

5. SDS-PAGE of recombinant and endogenous erythropoietins: Benefits and limitations of the method for application in doping control;Reichel;Drug Test. Anal.,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of erythropoietin biosimilars Epotin™, Hemax® and Jimaixin™ by electrophoretic methods used for doping control analysis and specific N-glycan analysis revealed structural differences from original epoetin alfa drug Eprex®;Journal of Pharmaceutical and Biomedical Analysis;2021-02

2. Serum‐free suspension cultured human cells can produce a high‐level of recombinant human erythropoietin;Engineering Reports;2020-05-05

3. Biosimilar and interchangeable: Inseparable scientific concepts?;British Journal of Clinical Pharmacology;2019-09-04

4. Characterization of erythropoietin biosimilars using mass spectrometric CID and HCD techniques;Journal of Liquid Chromatography & Related Technologies;2019-05-21

5. Mass spectrometry for protein sialoglycosylation;Mass Spectrometry Reviews;2017-12-11